Samsung Comprehensive Cancer Center

Urologic Cancer Center

Multidisciplinary, Patient-Centered Excellence

The Urologic Cancer Center is staffed by a world-class team, including seven professors of urology, three professors of hematology and oncology, three professors of radiation oncology, three professors of radiology, two professors of pathology and one professor of nuclear medicine, as well as nurses specializing in urologic cancers. We provide exceptional diagnostic services, treatment, and follow-up care through a highly coordinated multidisciplinary system, helping patients achieve the best possible quality of life after treatment. Regular conferences allow each department to share specialized expertise, ensuring that every patient benefits from the most advanced and evidence-based treatment strategies.

Expert Faculty, Cutting-Edge Treatments

Our center delivers state-of-the-art care by combining the expertise of leading specialists with the latest medical technologies. We actively perform robotic and laparoscopic surgeries, as well as cryotherapy (RFA), with a focus on preserving quality of life. Our comprehensive approach incorporates: next-generation targeted therapy guided by genomic profiling, 5th generation da Vinci robot surgery, immuno-cancer drugs and antibody-drug conjugate (ADC), intensity-controlled radiation therapy, proton therapy, and prostate cancer Pluvicto therapy.

Specialized Expertise

Bladder Preservation Clinic (Patient-Centered, Face-to Face Multidisciplinary Care)

While radical cystectomy remains the standard treatment for muscle-invasive bladder cancer, selected patients may benefit from bladder-preserving strategies such as transurethral resection combined with chemotherapy and/or radiation therapy. Our multidisciplinary team evaluates each case in detail to determine eligibility for bladder preservation, ensuring treatment is tailored to each patient's condition and goals.

URO-Oncology Conference & Tumor board

Every week, faculty and clinical instructors from Urology, Hematology, Radiation Oncology, Radiology, Pathology, Nuclear Medicine-together with specialized nurses and center coordinators-participate in multidisciplinary conferences. These meetings review each patient's diagnosis, prognosis, and treatment options, enabling consensus-based decisions that ensure the highest standard of care.

Robotic Surgery (Minimally Invasive Surgery)

For prostate cancer, we aim for minimally invasive surgery using robotic-assisted laparoscopic techniques, performed when appropriate based on tumor stage. We also perform robotic partial nephrectomy for small kidney tumors. Robotic surgery allows for rapid and precise tumor removal, reduced postoperative pain and scarring, and maximal preservation of organ function.

Innovative PSMA PET Imaging

PSMA PET imaging uses a radiopharmaceutical that selectively binds to prostate-specific membrane antigen (PSMA), which is overexpressed in prostate cancer cells. This advanced imaging technique can detect even minute cancer deposits that are difficult to identify with conventional imaging. By enabling more precise detection, PSMA PET supports highly standardized treatment planning, improving both patient satisfaction and treatment outcomes.